Epithelial Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Epithelial Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-07-18Clinical Trial Update: Evaluation of PLD Combined With Carboplatin Versus Paclitaxel Plus Carboplatin in the First-line Treatment of Epithelial Ovarian Cancer [Phase 4]
Phase 4 trial evaluating pegylated liposomal doxorubicin (PLD) plus carboplatin versus paclitaxel plus carboplatin as first-line therapy for…
-
CLINICAL_TRIALS trial_result · 2022-06-10Clinical Trial Update: Study of Pembrolizumab With or Without CC-486 in Patients With Platinum-resistant Ovarian Cancer [Phase 2]
Phase 2 trial evaluating pembrolizumab with or without CC-486 in platinum-resistant ovarian cancer was terminated; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-05-23Clinical Trial Update: A Phase II Trial to Explore Niraparib and Anlotinib Maintenance Retreatment in Platinum-Sensitive Recurrent Ovarian Cancer Patients Previously Treated With PARPi [Phase 2]
Phase II trial evaluating niraparib and anlotinib as maintenance retreatment in platinum-sensitive recurrent ovarian cancer after prior PARP…
-
CLINICAL_TRIALS trial_result · 2022-04-19Clinical Trial Update: A Study to Examine Olaparib Maintenance Retreatment in Patients With Epithelial Ovarian Cancer. [Phase 3]
Phase 3 trial evaluating maintenance retreatment with olaparib in epithelial ovarian cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-01-26Clinical Trial Update: PARP Inhibitor Oral Maintenance in Low-Risk Ovarian Cancer [Phase 4]
Phase 4 clinical trial update of PARP inhibitor as oral maintenance in low-risk ovarian cancer is underway, status currently UNKNOWN.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-12-08Clinical Trial Update: An Open Label Extension Study of the Efficacy of MORAb-003 [Phase 2]
Open-label extension study of MORAb-003 (epithelial ovarian cancer) in Phase 2 has been terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2021-12-01Clinical Trial Update: Clinical Trial of Chemotherapy, Oregovomab and Nivolumab in Patients With Epithelial Cancer of Ovarian, Tubal or Peritoneal Origin [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating chemotherapy, oregovomab, and nivolumab in patients with epithelial ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2021-07-30Clinical Trial Update: Efficacy and Safety of SG001 Combined With PLD in Patients With Platinum-resistant Relapsed EOC [Phase 2]
Phase 2 clinical trial evaluating efficacy and safety of SG001 in combination with PLD for platinum-resistant relapsed epithelial ovarian ca…
-
CLINICAL_TRIALS trial_result · 2021-07-13Clinical Trial Update: A Study of Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARIEL2) [Phase 2]
Phase 2 study ARIEL2 evaluating rucaparib in platinum-sensitive relapsed high-grade ovarian/fallopian tube/primary peritoneal cancer complet…
-
CLINICAL_TRIALS trial_result · 2021-06-18Clinical Trial Update: Study of DPX-Survivac Therapy in Patients With Recurrent Ovarian Cancer [Phase 1, Phase 2]
Clinical trial update for DPX-Survivac in recurrent ovarian-related cancers, spanning Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2021-06-15Clinical Trial Update: A Study to Evaluate Rucaparib in Combination With Nivolumab in Patients With Selected Solid Tumors (ARIES) [Phase 2]
Phase 2 trial ARIES evaluating rucaparib with nivolumab in selected solid tumors has been terminated; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-04-19Clinical Trial Update: A Study of Oral Gimatecan in Platinum-Resistant Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer [Phase 2]
Phase 2 study evaluating oral gimatecan in platinum-resistant epithelial ovarian cancer and related abdominal cancers is ongoing with unknow…
-
CLINICAL_TRIALS trial_result · 2021-02-09Clinical Trial Update: Neoadjuvant Therapy for Ovarian Cancer [Phase 2]
Phase 2 neoadjuvant therapy trial for epithelial ovarian cancer with involvement of primary peritoneal cancer completed; results posted.
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: Postoperative Adjuvant Chemotherapy With Bevacizumab and Maintenance Bevacizumab After Neoadjuvant Chemotherapy for Ovarian Cancer [Phase 2]
Phase 2 trial evaluating postoperative adjuvant chemotherapy with bevacizumab and maintenance bevacizumab following neoadjuvant therapy in e…
-
CLINICAL_TRIALS trial_result · 2020-12-03Clinical Trial Update: Cell-free DNA Methylation for Epithelial Ovarian Cancer [Phase 2]
Phase 2 clinical trial update investigating cell-free DNA methylation as a biomarker in epithelial ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2020-11-12Clinical Trial Update: Anti-PD-L1 and SAbR for Ovarian Cancer [Phase 2]
Phase 2 trial of anti-PD-L1 therapy with SAbR (stereotactic ablative radiotherapy) in recurrent epithelial ovarian/fallopian tube/primary pe…
-
CLINICAL_TRIALS trial_result · 2020-09-09Clinical Trial Update: A Randomized Prospective Trail of HIPEC in Recurrent Ovarian Cancer Patients With HRR Mutation [Phase 3]
Phase 3 randomized trial investigating HIPEC in recurrent ovarian cancer patients with HRR gene mutations; status not yet determined.
-
CLINICAL_TRIALS trial_result · 2020-08-27Clinical Trial Update: Stratified Evaluation of PDS and NACT-IDS in Ovarian Cancer (FOCUS) [Phase 3]
Phase 3 trial investigating stratified evaluation of PDS and NACT-IDS in ovarian cancer is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2020-08-10Clinical Trial Update: 68Ga-FAPI-04 and 18F-FDG PET/CT in Patients With Epithelial Ovarian Cancer: Compared With Histological Findings [Phase 2]
Phase 2 trial evaluating 68Ga-FAPI-04 and 18F-FDG PET/CT in epithelial ovarian cancer with comparison to histology findings.
-
CLINICAL_TRIALS trial_result · 2020-07-09Clinical Trial Update: A Study of Pembrolizumab on the Tumoral Immunoprofile of Gynecologic Cancers [EARLY_Phase 1]
Early-phase study evaluating pembrolizumab in gynecologic cancers; study completed with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-06-09Clinical Trial Update: A Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Women With Folate Receptor (FR) Alpha Positive Advanced Epithelial Ovarian Cancer (EOC), Primary Peritoneal or Fallopian Tube Cancer [Phase 3]
Phase 3 trial comparing mirvetuximab soravtansine to investigator's choice chemotherapy in FR alpha-positive advanced epithelial ovarian, pr…
-
CLINICAL_TRIALS trial_result · 2020-05-29Clinical Trial Update: Cytoreductive Surgery(CRS) Plus Hyperthermic Intraperitoneal Chemotherapy(HIPEC) With Lobaplatin in Advanced and Recurrent Epithelial Ovarian Cancer [Phase 3]
Phase 3 trial update on cytoreductive surgery with HIPEC using lobaplatin for advanced and recurrent epithelial ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2020-03-12Clinical Trial Update: Karenitecin Versus Topotecan in Patients With Advanced Epithelial Ovarian Cancer [Phase 3]
Phase 3 trial comparing karenitecin to topotecan in advanced epithelial ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-02-28Clinical Trial Update: Tivozanib in Recurrent, Platinum-Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial update for tivozanib in recurrent platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer has completed with …
-
CLINICAL_TRIALS trial_result · 2020-02-17Clinical Trial Update: Intraoperative Hyperthermic Intraperitoneal Chemotherapy With Ovarian Cancer [Phase 2, Phase 3]
Clinical trial update for intraoperative hyperthermic intraperitoneal chemotherapy in epithelial ovarian cancer completed across Phase 2 and…